Document:

<PAGE>

                                                                  Exhibit 10.38

                                PROMISSORY NOTE

$150,000.00 Mandeville, Louisiana                                  June 9, 2000

     For value received, RX Technology, Inc. promises to pay Merchants Trade
& Finance Co., 445 5th Avenue, New York, New York 10016 ("Holder"), the sum
of ONE HUNDRED FIFTY THOUSAND AND NO/100 ($150,000.00) DOLLARS payable over
six months as follows: principal shall be payable monthly in installments of
EIGHTEEN THOUSAND SEVEN HUNDRED FIFTY AND NO/100 ($18,750.00) DOLLARS on the
fifteenth (15th) day of each month beginning on August 15, 2000 until
November 15, 2000 and the principal balance of SEVENTY FIVE THOUSAND AND
NO/100 ($75,000.00) DOLLARS shall be payable on the fifteenth (15th) day of
December, 2000; interest shall be payable monthly in the amount of ONE
THOUSAND THREE HUNDRED SEVENTY-FIVE AND NO/100 ($1,375.00) DOLLARS on the
fifteenth (15th) day of each month beginning on July 15, 2000 and continuing
until October 15, 2000 and ONE THOUSAND ONE HUNDRED TWENTY-FIVE AND NO/100
($1,125.00) DOLLARS on the fifteenth (15th) day of both November and
December, 2000.

     All obligations contained herein shall be governed by Louisiana law and
the applicable laws of the United States of America and any litigation
relating to the obligations contained herein shall be conducted exclusively
before the courts of the State of Louisiana, the parties hereto consenting to
the jurisdiction of said courts.

                                          RX TECHNOLOGY, INC.

                                          By: /s/ Donald Rex Gay
                                              ---------------------

                                          Its:  President
                                               --------------------<PAGE>

                                                                   EXHIBIT 10.39

[RX TECHNOLOGY LETTERHEAD]

CONFIDENTIAL

May 5, 2000

Mr. Douglas A. Dunbar
102 Pecaniere Place
Mandeville, LA 70471

Dear Mr. Dunbar:

RX Technology Holdings, Inc. and RX Technology, Inc. (collectively, "RX
Technology") are pleased to offer you a position with our respective companies.
As discussed, you will assume the position of Vice President and Chief Financial
Officer reporting directly to me. This letter will serve to confirm our
understanding of your acceptance of these positions.

1.  You will compensated with a base salary of $5,208.33 per semi-monthly pay
    period (equivalent to $125,000 on an annualized basis). You will also be
    eligible for bonuses and base salary increases based upon performance.

2.  Effective as of commencement of your employment, you will be granted
    fully-vested rights to purchase 30,000 shares of RX Technology Holdings,
    Inc. Common Stock ("RXT Common") exercisable at $1.75 per share.

3.  During your period of employment with RX Technology, you will accrue rights
    to purchase 100,000 shares of RXT Common exercisable at $1.75 per share for
    the first year, with such rights to accrue and become vested quarterly
    during your period of employment and each following year at fair market
    value to be determined at the date of grant.

4.  Our offer to hire you is contingent upon your submission of satisfactory
    proof of you identity, your legal authorization to work in the United States
    and signing of an Employee Confidentiality Agreement, if requested. If you
    fail to submit proof of such work authorization, federal law prohibits us
    from hiring you.

5.  I will expect you to begin work at such time as we mutually agree at our
    Mandeville, LA office.

6.  This offer is valid until Friday, May 12, 2000 at 5:005p.m., New Orleans
    Time.

<PAGE>

Mr. Douglas A. Dunbar
May 5, 2000
Page 2

Mr. Dunbar, if you agree with and accept the terms of this offer of employment,
please indicate such agreement by signing below and returning this copy to me.
The enclosed executed copy of this letter is for your files.

I am confident your employment with RX Technology will prove mutually
beneficial, and I look forward to having you join us.

                                          Very truly yours,
                                          RX Technology Holdings, Inc.
                                          RX Technology, Inc.

                                                    /s/ DONALD REX GAY

                                          --------------------------------------
                                                        D. Rex Gay
                                             Chairman of the Board, President
                                               and Chief Executive Officer

Accepted By:

        /s/ DOUGLAS A. DUNBAR
--------------------------------------
          Douglas A. Dunbar

Date: 5/8/00Exhibit 10.1

THIS COMMON STOCK PURCHASE WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE
TRANSFERRED IN VIOLATION OF SUCH ACT, THE RULES AND REGULATIONS THEREUNDER OR
THE PROVISIONS OF THIS COMMON STOCK PURCHASE WARRANT.

                    Number of Shares of Common Stock: 225,000

                          COMMON STOCK PURCHASE WARRANT

                           To Purchase Common Stock of

                              Symposium Corporation

         THIS IS TO CERTIFY THAT The Shaar Fund Ltd., or its registered assigns,
is entitled, at any time from the Funding Date (as hereinafter defined) to the
Expiration Date (as hereinafter defined), to purchase from SYMPOSIUM
CORPORATION, a Delaware corporation (the "Company"), 225,000 shares of Common
Stock (as hereinafter defined and subject to adjustment as provided herein), in
whole or in part, including fractional parts, at a purchase price equal to
$1.485 per share, all on the terms and conditions and pursuant to the provisions
hereinafter set forth.

1.    DEFINITIONS

                  As used in this Common Stock Purchase Warrant (this
"Warrant"), the following terms have the respective meanings set forth below:

                  "Additional Shares of Common Stock" shall mean all shares of
Common Stock issued by the Company after the Funding Date, other than Warrant
Shares.

                  "Business Day" shall mean any day that is not a Saturday or
Sunday or a day on which banks are required or permitted to be closed in the
State of New York.

                  "Certificate of Designation" shall mean that certificate
indicating the designations, rights and preferences of the Company's Series A
Convertible Preferred Stock, as filed with the Office of the Secretary of State
of the State of Delaware, as of June 9, 2000.

                  "Commission" shall mean the Securities and Exchange Commission
or any other federal agency then administering the Securities Act and other
federal securities laws.

                  "Common Stock" shall mean (except where the context otherwise
indicates) the Common Stock, par value $0.001, of the Company as constituted on
the Funding Date, and any capital stock into which such Common Stock may
thereafter be changed, and shall also include (i) capital stock of the Company
of any other class (regardless of how denominated) issued to the holders of
shares of Common Stock upon any reclassification thereof which is also not
preferred

<PAGE>

as to dividends or assets over any other class of stock of the Company and which
is not subject to redemption and (ii) shares of common stock of any successor or
acquiring corporation received by or distributed to the holders of Common Stock
of the Company in the circumstances contemplated by Section 4.4.

                  "Convertible Securities" shall mean evidences of indebtedness,
shares of stock or other securities which are convertible into or exchangeable,
with or without payment of additional consideration in cash or property, for
shares of Common Stock, either immediately or upon the occurrence of a specified
date or a specified event.

                  "Current Warrant Price" shall mean, in respect of a share of
Common Stock at any date herein specified, the price at which a share of Common
Stock may be purchased pursuant to this Warrant on such date, which price as of
the Funding Date, is $1.485 subject to adjustment in accordance the terms of
this Warrant.

                  "Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended, or any successor federal statute, and the rules and regulations of
the Commission thereunder, all as the same shall be in effect from time to time.

                  "Exercise Period" shall mean the period during which this
Warrant is exercisable pursuant to Section 2.1.

                  "Expiration Date" shall mean the date that is five years after
the Funding Date.

                  "Fundamental Corporate Changes" shall have the meaning set
forth in Section 4.4.

                  "Funding Date" means the date and time of the issuance and
sale of the Initially Issued Preferred Shares and the Initially Issued Warrants
(each as defined in the Securities Purchase Agreement).

                  "Holder" shall mean the Person in whose name the Warrant or
Warrant Shares set forth herein is registered on the books of the Company
maintained for such purpose.

                  "Market Price" shall have the meaning set forth in the
Certificate of Designation.

         "Other Property" shall have the meaning set forth in Section 4.4.

         "Outstanding" shall mean, when used with reference to Common Stock, at
any date as of which the number of shares thereof is to be determined, all
issued shares of Common Stock, except shares then owned or held by or for the
account of the Company or any subsidiary thereof, and shall include all shares
issuable in respect of outstanding scrip or any certificates representing
fractional interests in shares of Common Stock.

         "Permitted Dilutive Issuance" shall mean any one or more of the
following: (i) the issuance of Common Shares by the Company within forty-five
(45) days after the Closing Date in connection with a currently contemplated
$1.1 million private placement; (ii) the

<PAGE>

issuance of Common Shares upon exercise of options or warrants that are
outstanding or committed to be issued on the Closing Date and listed on Schedule
III A 1.1 or III A 1.2 to the Securities Purchase Agreement (and pursuant to the
terms in effect on the date hereof); (iii) the issuance of options pursuant to
employee stock option agreements or stock incentive plans of the Company as in
effect from time to time; (iv) the issuance of up to 1,000,000 Common Shares to
RLP Holdings L.P. ("RLP") in satisfaction of the Company's obligation to
purchase for $500,000 a $500,000 principal amount promissory note issued by
AmeriNet, Inc. to RLP; (v) the adjustment of the exercise price or rate of
options or warrants referred to in clauses (ii) and (iii) above, or adjustments
to the conversion price of shares of Series B Preferred Stock and Series C
Preferred Stock (and/or the adjustment of the number of Common Shares issuable
upon exercise thereof), pursuant to contractual anti-dilution provisions in
effect as of the Closing Date providing for (A) adjustments upon the occurrence
of events such as stock splits, stock dividends, reverse stock splits,
recapitalizations, combinations and mergers, or (B) in the case of options or
warrants referred to in clauses (ii) or (iii) above (but not in the case of
shares of Series B Preferred Stock or Series C Preferred Stock),
weighted-average anti-dilution adjustments upon the issuance of Common Shares or
Common Shares Equivalents for consideration less than the applicable exercise
price of such options or warrants, provided that this clause (B) shall not
include any "ratchet" type anti-dilution adjustment (collectively, the
"Permitted Adjustments"); and (vi) the issuance of Common Shares (A) upon
exercise of all options and warrants and referred to in clauses (ii) and (iii)
above, in each case in accordance with the terms of such options and warrants in
effect as of the Closing Date (with respect to options and warrants referred to
in clause (ii) above) or in effect as of the date of issuance (with respect to
options referred to pursuant to clause (iii) above), or (B) upon conversion of
shares of Series B Preferred Stock and Series C Preferred Stock, subject, in
each case, to Permitted Adjustments.

         "Person" shall mean any individual, sole proprie-torship, partnership,
joint venture, trust, incorporated organization, association, corporation,
institution, public benefit corporation, entity or government (whether federal,
state, county, city, municipal or otherwise, including, without limitation, any
instrumentality, division, agency, body or department thereof).

         "Registration Rights Agreement" shall mean the Registration Rights
Agreement dated a date even herewith by and between the Company and The Shaar
Fund Ltd., as it may be amended from time to time.

         "Restricted Common Stock" shall mean shares of Common Stock which are,
or which upon their issuance on the exercise of this Warrant would be, evidenced
by a certifi-cate bearing the restrictive legend set forth in Section 9.1(b).

         "Securities Act" shall mean the Securities Act of 1933, as amended, or
any successor federal statute, and the rules and regulations of the Commission
thereunder, all as the same shall be in effect at the time.

         "Securities Purchase Agreement" shall mean the Securities Purchase
Agreement dated as of a date even herewith by and between the Company and The
Shaar Fund, Ltd. as it may be amended from time to time.

         "Transfer" shall mean any disposition of any Warrant or Warrant Shares
or of any

<PAGE>

interest in either thereof, which would constitute a sale thereof within the
meaning of the Securities Act.

         "Transfer Notice" shall have the meaning set forth in Section 9.2.

         "Warrants" shall mean this Warrant and all warrants issued upon
transfer, division or combination of, or in substitution for, any thereof. All
Warrants shall at all times be identical as to terms and conditions and date,
except as to the number of shares of Common Stock for which they may be
exercised.

         "Warrant Price" shall mean an amount equal to (i) the number of shares
of Common Stock being purchased upon exercise of this Warrant pursuant to
Section 2.1, multiplied by (ii) the Current Warrant Price as of the date of such
exercise.

         "Warrant Shares" shall mean the shares of Common Stock purchased by the
holders of the Warrants upon the exercise thereof.

2.    EXERCISE OF WARRANT

      2.1 Manner of Exercise. From and after the Funding Date and until 5:00
P.M., New York City time, on the Expiration Date, Holder may exercise this
Warrant, on any Business Day, in increments of 10,000 shares of Common Stock
purchasable hereunder.

                  In order to exercise this Warrant, in whole or in part, Holder
shall deliver to the Company at its principal office at 410 Park Avenue, Suite
830 New York, New York 10022, or at the office or agency designated by the
Company pursuant to Section 12, (i) a written notice of Holder's election to
exercise this Warrant, which notice shall specify the number of shares of Common
Stock to be purchased, (ii) payment of the Warrant Price in cash or by wire
transfer or cashier's check drawn on a United States bank and (iii) this
Warrant. Such notice shall be substantially in the form of the subscription form
appearing at the end of this Warrant as Exhibit A, duly executed by Holder or
its agent or attorney. Upon receipt of the items referred to in clauses (i),
(ii) and (iii) above, the Company shall, as promptly as practicable, and in any
event within ten (10) Business Days thereafter, execute or cause to be executed
and deliver or cause to be delivered to Holder a certificate or certificates
representing the aggregate number of full shares of Common Stock issuable upon
such exercise, together with cash in lieu of any fraction of a share, as
hereinafter provided. The stock certificate or certificates so delivered shall
be, to the extent possible, in such denomination or denominations as Holder
shall request in the notice and shall be registered in the name of Holder or,
subject to Section 9, such other name as shall be designated in the notice. This
Warrant shall be deemed to have been exercised and such certificate or
certificates shall be deemed to have been issued, and Holder or any other Person
so designated to be named therein shall be deemed to have become a holder of
record of such shares for all purposes, as of the date the notice, together with
the cash or check or checks and this Warrant, is received by the Company as
described above and all taxes required to be paid by Holder, if any, pursuant to
Section 2.2 prior to the issuance of such shares have been paid. If this Warrant
shall have been exercised in part, the Company shall, at the time of delivery of
the certificate or certificates representing Warrant Shares, deliver to Holder a
new Warrant evidencing the rights of Holder to purchase the unpurchased shares
of Common Stock called for

<PAGE>

by this Warrant, which new Warrant shall in all other respects be identical with
this Warrant, or, at the request of Holder, appropriate notation may be made on
this Warrant and the same returned to Holder. Notwithstanding any provision
herein to the contrary, the Company shall not be required to register shares in
the name of any Person who acquired this Warrant (or part hereof) or any Warrant
Shares otherwise than in accordance with this Warrant.

      2.2 Payment of Taxes and Charges. All shares of Common Stock issuable upon
the exercise of this Warrant pursuant to the terms hereof shall be validly
issued, fully paid and nonassessable, and without any preemptive rights. The
Company shall pay all expenses in connection with, and all taxes and other
governmental charges (excluding income and related taxes) that may be imposed
with respect to, the issue or delivery thereof, unless such tax or charge is
imposed by law upon Holder, in which case such taxes or charges shall be paid by
Holder. The Company shall not be required, however, to pay any tax or other
charge imposed in connection with any transfer involved in the issue of any
certificate for shares of Common Stock issuable upon exercise of this Warrant in
any name other than that of Holder, and in such case the Company shall not be
required to issue or deliver any stock certificate until such tax or other
charge has been paid or it has been established to the satisfaction of the
Company that no such tax or other charge is due.

      2.3 Fractional Shares. The Company shall not be required to issue a
fractional share of Common Stock upon exercise of any Warrant. As to any
fraction of a share which Holder would otherwise be entitled to purchase upon
such exercise, the Company shall pay a cash adjustment in respect of such final
fraction in an amount equal to the same fraction of the Market Price per share
of Common Stock as of the Initial Funding Date.

      2.4 Continued Validity. A holder of shares of Common Stock issued upon the
exercise of this Warrant, in whole or in part (other than a holder who acquires
such shares after the same have been publicly sold pursuant to a Registration
Statement under the Securities Act or sold pursuant to Rule 144 thereunder),
shall continue to be entitled with respect to such shares to all rights to which
it would have been entitled as Holder under Sections 9, 10 and 14 of this
Warrant. The Company will, at the time of exercise of this Warrant, in whole or
in part, upon the request of Holder, acknowledge in writing, in form reasonably
satisfactory to Holder, its continuing obligation to afford Holder all such
rights; provided, however, that if Holder shall fail to make any such request,
such failure shall not affect the continuing obligation of the Company to afford
to Holder all such rights.

3.    TRANSFER, DIVISION AND COMBINATION

      3.1 Transfer. Subject to compliance with the Securities Purchase Agreement
and this Section 3.1 and Section 9 herein, transfer of this Warrant and all
rights hereunder, in whole or in part, shall be registered on the books of the
Company to be maintained for such purpose, upon surrender of this Warrant at the
principal office of the Company referred to in Section 2.1 or the office or
agency designated by the Company pursuant to Section 12, together with a written
assignment of this Warrant substantially in the form of Exhibit B hereto duly
executed by Holder

<PAGE>

or its agent or attorney and funds sufficient to pay any transfer taxes payable
upon the making of such transfer. Upon such surrender and, if required, such
payment, the Company shall, subject to Section 9, execute and deliver a new
Warrant or Warrants in the name of the assignee or assignees and in the
denomination specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. A Warrant, if properly assigned in
compliance with Section 9, may be exercised by a new Holder for the purchase of
shares of Common Stock without having a new warrant issued.

      3.2 Division and Combination. Subject to Section 3.1 and 9, this Warrant
may be divided or combined with other Warrants upon presentation hereof at the
aforesaid office or agency of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by Holder or its agent or attorney. Subject to compliance with Section
3.1 and with Section 9, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice.

      3.3 Expenses. The Company shall prepare, issue and deliver at its own
expense (other than transfer taxes) the new Warrant or Warrants under this
Section 3.

      3.4 Maintenance of Books. The Company agrees to maintain, at its aforesaid
office or agency, books for the registration and the registration of transfer of
the Warrants.

4.    ADJUSTMENTS

      The number of shares of Common Stock for which this Warrant is
exercisable, or the price at which such shares may be purchased upon exercise of
this Warrant, shall be subject to adjustment from time to time as set forth in
this Section 4. The Company shall give Holder notice of any event described
below which requires an adjustment pursuant to this Section 4 at the time of
such event.

      4.1 Stock Dividends, Subdivisions and Combinations. If at any time the
Company shall:

         (a) take a record of the holders of its Common Stock for the purpose of
    entitling them to receive a dividend payable in, or other distribution of,
    Additional Shares of Common Stock,

         (b) subdivide its outstanding shares of Common Stock into a larger
    number of shares of Common Stock, or

         (c) combine its outstanding shares of Common Stock into a smaller
    number of shares of Common Stock,

then (i) the number of shares of Common Stock for which this Warrant is
exercisable immediately after the occurrence of any such event shall be adjusted
to equal the number of

<PAGE>

shares of Common Stock which a record holder of the same number of shares of
Common Stock for which this Warrant is exercisable immediately prior to the
occurrence of such event would own or be entitled to receive after the
happen-ing of such event, and (ii) the Current Warrant Price shall be adjusted
to equal (A) the Current Warrant Price multi-plied by the number of shares of
Common Stock for which this Warrant is exercisable immediately prior to the
adjustment divided by (B) the number of shares for which this Warrant is
exercisable immediately after such adjustment.

      4.2 Certain Other Distributions. If at any time the Company shall take a
record of the holders of its Common Stock for the purpose of entitling them to
receive any dividend or other distribution of:

         (a) cash,

         (b) any evidences of its indebtedness, any shares of its stock or any
    other securities or property of any nature whatsoever (other than cash,
    Convertible Securities or Additional Shares of Common Stock), or

         (c) any warrants or other rights to subscribe for or purchase any
    evidences of its indebtedness, any shares of its stock or any other
    securities or property of any nature whatsoever (other than cash,
    Convertible Securities or Additional Shares of Common Stock),

then Holder shall be entitled to receive such dividend or distribution as if
Holder had exercised this Warrant. A reclassification of the Common Stock (other
than a change in par value, or from par value to no par value or from no par
value to par value) into shares of Common Stock and shares of any other class of
stock shall be deemed a distribution by the Company to the holders of its Common
Stock of such shares of such other class of stock within the meaning of this
Section 4.2 and, if the outstanding shares of Common Stock shall be changed into
a larger or smaller number of shares of Common Stock as a part of such
reclassification, such change shall be deemed a subdivision or combination, as
the case may be, of the outstanding shares of Common Stock within the meaning of
Section 4.1.

      4.3 Other Provisions Applicable to Adjustments under this Section. The
following provisions shall be applicable to the making of adjustments of the
number of shares of Common Stock for which this Warrant is exercisable and the
Current Warrant Price provided for in this Section 4:

         (a) When Adjustments to Be Made. The adjustments required by this
    Section 4 shall be made whenever and as often as any specified event
    requiring an adjustment shall occur. For the purpose of any adjustment, any
    specified event shall be deemed to have occurred at the close of business on
    the date of its occurrence.

         (b) Fractional Interests. In computing adjust-ments under this Section
    4, fractional interests in Common Stock shall be taken into account to the
    nearest 1/10th of a share.

<PAGE>

         (c) When Adjustment Not Required. If the Company shall take a record of
    the holders of its Common Stock for the purpose of entitling them to receive
    a dividend or distribution or subscription or purchase rights and shall,
    thereafter and before the distribution to stock-holders thereof, legally
    abandon its plan to pay or deliver such dividend, distribution, subscription
    or purchase rights, then thereafter no adjustment shall be required by
    reason of the taking of such record and any such adjustment previously made
    in respect thereof shall be rescinded and annulled.

         (d) Challenge to Good Faith Determination. Whenever the Board of
    Directors of the Company shall be required to make a determination in good
    faith of the fair value of any item under this Section 4, such determination
    may be challenged in good faith by the Holder, and any dispute shall be
    resolved by an investment banking firm of recognized national standing
    selected by the Company and reasonably acceptable to the Holder.

      4.4 Reorganization, Reclassification, Merger, Consolidation or Disposition
of Assets. In case the Company shall reorganize its capital, reclassify its
capital stock, consolidate or merge with or into another Person (where the
Company is not the survivor or where there is a change in or distribution with
respect to the Common Stock of the Company), or sell, convey, transfer or
otherwise dispose of all or substantially all its property, assets or business
to another Person, or effectuate a transaction or series of related transactions
in which more than 50% of the voting power of the Company is disposed of (each,
a "Fundamental Corporate Change") and, pursuant to the terms of such Fundamental
Corporate Change, shares of common stock of the successor or acquiring
corporation, or any cash, shares of stock or other securities or property of any
nature whatsoever (including warrants or other subscription or purchase rights)
in addition to or in lieu of common stock of the successor or acquiring
corporation ("Other Property"), are to be received by or distributed to the
holders of Common Stock of the Company, then Holder shall have the right
thereafter to receive, upon exercise of the Warrant, such number of shares of
common stock of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and Other Property as is receivable upon or as a
result of such Fundamental Corporate Change by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such
Fundamental Corporate Change. In case of any such Fundamental Corporate Change,
the successor or acquiring corporation (if other than the Company) shall
expressly assume the due and punctual observance and performance of each and
every covenant and condition of this Warrant to be performed and observed by the
Company and all the obligations and liabilities hereunder, subject to such
modifications as may be deemed appropriate (as determined by resolution of the
Board of Directors of the Company) in order to provide for adjustments of shares
of Common Stock for which this Warrant is exercisable which shall be as nearly
equivalent as practicable to the adjustments provided for in this Section 4. For
purposes of this Section 4.4, "common stock of the successor or acquiring
corporation" shall include stock of such corporation of any class which is not
preferred as to dividends or assets over any other class of stock of such
corporation and which is not subject to redemption and shall also include any
evidences of indebtedness, shares of stock or other securities which are
convertible into or exchangeable for any such stock, either immediately or upon
the arrival of a specified date or the happening of a specified event and any
warrants or other rights to subscribe for or purchase any such stock. The
foregoing provisions of this Section 4.4 shall similarly apply to successive
Fundamental Corporate Change.

<PAGE>

      4.5 Other Action Affecting Common Stock. (a) Except with respect to
Permitted Dilutive Issuance and/or issuances and sales governed by Section
4.5(b) below, if the Company issues and sells pursuant to an exemption from
registration under the Securities Act (A) Common Shares at a purchase price that
is lower than the Current Warrant Price on the date of issuance of such Common
Shares, (B) warrants or options with an exercise price on the date of issuance
thereof that is lower than the Current Warrant Price for the Holder on such
date, or (C) convertible, exchangeable or exercisable securities with a right to
convert or exchange at lower than the Current Market Price on the date of
issuance or conversion, as applicable, of such convertible, exchangeable or
exercisable securities, then the price at which Common Shares may be purchased
upon exercise of this Warrant shall be reduced to equal the lowest of the
Current Warrant Price then in effect or any such purchase price, exercise price
or exchange price, and the number of shares of Common Stock for which this
Warrant is exercisable pursuant to Section 1 shall be correspondingly adjusted.
Notwithstanding the foregoing, if an adjustment is made upon issuance of
warrants, options or convertible, exercisable or exchangeable securities
pursuant to clause (B) or (C) above, no further adjustment pursuant to clause
(A) shall be made upon issuance of Common Shares upon exercise, conversion or
exchange thereof.

      (b) Notwithstanding anything to the contrary herein, if at any time, other
than pursuant to a Permitted Dilutive Issuance, the Company (i) (A) issues to
the holders of the Company's Series B Preferred Stock or Series C Preferred
Stock warrants or options to purchase Common Shares, or securities convertible
into or exchangeable for Common Shares, in any such case, at an exercise or
conversion price less than the Current Warrant Price then in effect, or (B)
issues and sells to such holders additional Common Shares (other than upon
exercise of previously issued options or warrants or conversion of previously
issued convertible securities pursuant to the terms in effect on the date
hereof) at a purchase price that is lower than the Current Warrant Price then in
effect (each, an "Issuance Event"), or (ii) adjusts the exercise price of
warrants or options, or the conversion price of convertible securities,
previously issued to the holders of the Company's Series B Preferred Stock or
Series C Preferred Stock to a price less than the Current Warrant Price then in
effect (an "Adjustment Event"), then, from and after the date of such Issuance
Event or Adjustment Event, the Warrant shall be reduced to equal the lowest of
the Current Warrant Price then in effect or the exercise price of the warrants
or options, the conversion price of the convertible securities or the purchase
price of the Common Shares issued pursuant to such Issuance Event or the
exercise price of previously issued warrants or options or previously issued
convertible securities as adjusted pursuant to such Adjustment Event, as the
case may be, and the number of Common Shares for which this Warrant is
exercisable pursuant to Section 1 will be correspondingly adjusted; provided,
however, that no reduction of the Warrant shall be made pursuant to this Section
4.5(b) as a result of the occurrence of any Issuance Event or Adjustment Event
unless the aggregate number of additional fully diluted Common Shares resulting
from such Issuance Event or Adjustment Event, as the case may be, and any
previous Issuance Events or Adjustment Events occurring on or after the Closing
Date (in each case calculated in accordance with the next sentence) exceeds
5,000,000, subject to adjustment for any stock-split or stock combination or
reverse stock split occurring after the Closing Date (the "Threshold Amount").
Shares counting toward the Threshold Amount shall

<PAGE>

consist of: (i) in the case of an Issuance Event involving the issuance of
options, warrants or convertible securities, all Common Shares issuable upon
exercise of such options or warrants or upon conversion of such convertible
securities; (ii) in the case of an Issuance Event involving the issuance and
sale of Common Shares, all Common Shares issued and sold; and (iii) in the case
of an Adjustment Event, a number of Common Shares equal to the difference
obtained by subtracting (x) the number of Common Shares issuable upon exercise
of the options or warrants or upon conversion of the convertible securities
subject to such Adjustment Event, before giving effect to such Adjustment Event
from (y) the number of Common Shares issuable upon exercise of such options or
warrants, or conversion of such convertible securities, after giving effect to
such Adjustment Event. Upon reaching the Threshold Amount, the price at which
Common Shares may be purchased upon exercise of the Warrant shall be adjusted to
equal the lowest of: (A) the Current Warranty Price then in effect, (B) the
price at which any Common Shares were sold, or the exercise or conversion price
of any options, warrants or convertible securities issued, pursuant to any
Issuance Event or (C) the adjusted exercise or conversion price of any options,
warrants or convertible securities subject to any Adjustment Event, provided
that for purposes of making such determination, only the second 2,500,000 shares
(the "Determination Shares") counting toward the Threshold Amount shall be
considered, and provided, further, that, if the Determination Shares include any
Common Shares, options, warrants or convertible securities issued for nominal
consideration or for consideration consisting of an agreement to modify or
release certain claims or contractual rights or other similar agreement to which
no monetary valuation is assigned, then such Common Shares, options, warrants or
convertible securities (the "Excluded Shares") shall not be considered
Determination Shares for purposes of making such adjustment, but, the Company
shall, concurrently with such adjustment, issue and sell to the Holder, at a
price equal to the par value of such shares, a number of Common Shares equal to
the number of Common Shares for which this Warrant is exercisable immediately
prior to such adjustment multiplied by a fraction the numerator of which is the
number of Excluded Shares and the denominator of which is 2,500,000 (subject to
adjustment in each case for any stock-split or stock combination or reverse
stock split occurring after the Closing Date).

      (c) Other than as specifically provided under this Section 4, if at any
time or from time to time the Company shall take any action in respect of its
Common Stock, which would have a materially adverse effect upon the rights of
the Holder, the number of shares of Common Stock for which this Warrant is
exercisable and/or the purchase price thereof shall be adjusted in such manner
as may be equitable in the circumstances, as determined in good faith by the
Board of Directors of the Company.

      4.6 Certain Limitations. Notwithstanding anything herein to the contrary,
the Company agrees not to enter into any transaction which, by reason of any
adjustment hereunder, would cause the Current Warrant Price to be less than the
par value per share of Common Stock.

5.    NOTICES TO HOLDER

      5.1 Notice of Adjustments. Whenever the number of shares of Common Stock
for which this Warrant is exercis-able, or whenever the price at which a share
of such Common Stock may be purchased upon exercise of the Warrants, shall be
adjusted pursuant to this Warrant, the Company shall forthwith prepare a
certificate to be executed by the chief financial officer of the Company setting
forth, in reasonable detail, the event requiring the adjustment and the method
by

<PAGE>

which such adjustment was calculated (including a description of the basis on
which the Board of Directors of the Company determined the fair value of any
evidences of indebtedness, shares of stock, other securities or property or
warrants or other subscription or purchase rights), specifying the number of
shares of Common Stock for which this Warrant is exercisable and describing the
number and kind of any other shares of stock or Other Property for which this
warrant is exercisable, and any change in the purchase price or prices thereof,
after giving effect to such adjustment or change. The Company shall promptly
cause a signed copy of such certificate to be delivered to the Holder in
accordance with Section 14.2. The Company shall keep at its office or agency
designated pursuant to Section 12 copies of all such certificates and cause the
same to be available for inspection at said office during normal business hours
by the Holder or any prospective purchaser of a Warrant designated by the
Holder.

      5.2 Notice of Corporate Action. If at any time

         (a) the Company shall take a record of the holders of its Common Stock
    for the purpose of entitling them to receive a dividend or other
    distribu-tion, or any right to subscribe for or purchase any evidences of
    its indebtedness, any shares of stock of any class or any other securities
    or property, or to receive any other right, or

         (b) there shall be any capital reorganization of the Company, any
    reclassification or recapitalization of the capital stock of the Company or
    any consolidation or merger of the Company with, or any sale, transfer or
    other disposition of all or substantially all the property, assets or
    business of the Company to, another corporation, or

         (c) there shall be a voluntary or involuntary dissolution, liquidation
    or winding up of the Company;

then, in any one or more of such cases, the Company shall give to Holder (i) at
least ten 10 business days' prior written notice of the date on which a record
date shall be selected for such dividend, distribution or right or for
determining rights to vote in respect of any such reorganization,
reclassifica-tion, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up, and (ii) in the case of any such
reorganization, reclassification, merger, conso-lidation, sale, transfer,
disposition, dissolution, liquida-tion or winding up, at least ten (10) business
days' prior written notice of the date when the same shall take place. Such
notice in accordance with the foregoing clause also shall specify (i) the date
on which any such record is to be taken for the purpose of such dividend,
distribution or right, the date on which the holders of Common Stock shall be
entitled to any such dividend, distribution or right, and the amount and
character thereof, and (ii) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Common Stock shall be
entitled to exchange their shares of Common Stock for securities or other
property deliverable upon such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up. Each such written notice shall be sufficiently given if addressed to Holder
at the last address of Holder appearing on the books of the Company and
delivered in accordance with Section 14.2.

<PAGE>

6.    NO IMPAIRMENT

         (a) The Company shall not by any action, including, without limitation,
    amending its certificate of incorporation or through any reorganization,
    transfer of assets, consolidation, merger, dissolution, issue or sale of
    securities or any other voluntary action, avoid or seek to avoid the
    observance or performance of any of the terms of this Warrant, but will at
    all times in good faith assist in the carrying out of all such terms and in
    the taking of all such actions as may be necessary or appropriate to protect
    the rights of Holder against impairment. Without limiting the generality of
    the foregoing, the Company will (i) not increase the par value of any shares
    of Common Stock receivable upon the exercise of this Warrant above the
    amount payable therefor upon such exercise immediately prior to such
    increase in par value, (ii) take all such action as may be necessary or
    appropriate in order that the Company may validly and legally issue fully
    paid and nonassessable shares of Common Stock upon the exercise of this
    Warrant, and (iii) use its best efforts to obtain all such authorizations,
    exemptions or consents from any public regulatory body having jurisdiction
    thereof as may be necessary to enable the Company to perform its obligations
    under this Warrant.

         (b) Upon the request of Holder, the Company will at any time during the
    period this Warrant is outstanding acknowledge in writing, in form
    satisfactory to Holder, the continuing validity of this Warrant and the
    obligations of the Company hereunder.

7.       RESERVATION AND AUTHORIZATION OF COMMON STOCK

         (a) From and after the Funding Date, the Company shall at all times
    reserve and keep available for issue upon the exercise of Warrants such
    number of its authorized but unissued shares of Common Stock as will be
    sufficient to permit the exercise in full of all outstanding Warrants. All
    shares of Common Stock which shall be so issuable, when issued upon exercise
    of any Warrant and payment therefor in accordance with the terms of such
    Warrant, shall be duly and validly issued and fully paid and nonassessable,
    and not subject to preemptive rights.

         (b) Before taking any action which would cause an adjustment reducing
    the Current Warrant Price below the then par value, if any, of the shares of
    Common Stock issuable upon exercise of the Warrants, the Company shall take
    any corporate action which may be necessary in order that the Company may
    validly and legally issue fully paid and non-assessable shares of such
    Common Stock at such adjusted Current Warrant Price.

         (c) Before taking any action which would result in an adjustment in the
    number of shares of Common Stock for which this Warrant is exercisable or in
    the Current Warrant Price, the Company shall obtain all such authorizations
    or exemptions thereof, or consents thereto, as may be necessary from any
    public regulatory body or bodies having jurisdiction thereof.

8.       TAKING OF RECORD; STOCK AND WARRANT TRANSFER BOOKS

<PAGE>

         In the case of all dividends or other distribu-tions by the Company to
the holders of its Common Stock with respect to which any provision of Section 4
refers to the taking of a record of such holders, the Company will in each such
case take such a record and will take such record as of the close of business on
a Business Day. The Company will not at any time, except upon dissolution,
liquidation or winding up of the Company, close its stock transfer books or
Warrant transfer books so as to result in preventing or delaying the exercise or
transfer of any Warrant.

9.       RESTRICTIONS ON TRANSFERABILITY

         The Warrants and the Warrant Shares shall not be transferred,
hypothecated or assigned before satisfaction of the conditions specified in this
Section 9, which conditions are intended to ensure compliance with the
provisions of the Securities Act with respect to the Transfer of any Warrant or
any Warrant Shares. Holder, by acceptance of this Warrant, agrees to be bound by
the provisions of this Section 9.

         9.1 Restrictive Legend. The Holder by accepting this Warrant and any
Warrant Shares agrees that unless registered under the Securities Act of 1933,
as amended (the "Securities Act"), subsequent to the Funding Date and prior to
the exercise hereof, this Warrant and the Warrant Shares issuable upon exercise
hereof may not be assigned or otherwise transferred unless and until (i) the
Company has received an opinion of counsel for the Holder reasonably
satisfactory to the Company and its counsel that such securities may be sold
pursuant to an exemption from registration under the Securities Act or (ii) a
registration statement relating to such securities has been filed by the Company
and declared effective by the Commission.

             (a) Each certificate for Warrant Shares issuable hereunder shall
    bear a legend as follows unless such securities have been sold pursuant to
    an effective registration statement under the Securities Act:

                           "These securities have not been registered under the
                  Securities Act of 1933, as amended (the "Securities Act"), or
                  the securities laws of any state, and are being offered and
                  sold pursuant to an exemption from the registration
                  requirements of the Securities Act and such laws. These
                  securities may not be sold or transferred except pursuant to
                  an effective registration statement under the Securities Act
                  or pursuant to an available exemption from the registration
                  requirements of the Securities Act or such other laws."

             (b) Except as otherwise provided in this Sec-tion 9, the Warrant
    shall be stamped or otherwise imprinted with a legend in substantially the
    following form:

                  "THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT
                  BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
                  AND MAY NOT

<PAGE>

                  BE TRANSFERRED IN VIOLATION OF SUCH ACT, THE RULES AND
                  REGULATIONS THEREUNDER OR THE PROVISIONS OF THIS WARRANT."

         9.2 Notice of Proposed Transfers. Prior to any Transfer or attempted
Transfer of any Warrants or any shares of Restricted Common Stock, the Holder
shall give ten days, prior written notice (a "Transfer Notice") to the Company
and its counsel of Holder's intention to effect such Transfer, describing the
manner and circumstances of the proposed Transfer, and obtain from counsel to
Holder who shall be reasonably satisfactory to the Company, an opinion that the
proposed Transfer of such Warrants or such Restricted Common Stock may be
effected without registration under the Securities Act. After receipt of the
Transfer Notice and opinion, the Company shall, within five (5) business days
thereof, notify the Holder as to whether such opinion is reasonably satisfactory
and, if so, such holder shall thereupon be entitled to Transfer such Warrants or
such Restricted Common Stock, in accordance with the terms of the Transfer
Notice. Each certificate, if any, evidencing such shares of Restricted Common
Stock issued upon such Transfer shall bear the restrictive legend set forth in
Section 9.1(b), and the Warrant issued upon such Transfer shall bear the
restrictive legend set forth in Section 9.1(c), unless in the opinion of such
counsel such legend is not required in order to ensure compliance with the
Securities Act. The Holder shall not be entitled to Transfer such Warrants or
such Restricted Common Stock until receipt of notice from the Company under this
Section 9.2 that such opinion is reasonably satisfactory.

         9.3 Required Registration. Pursuant to the terms and conditions set
forth in the Registration Rights Agreement, the Company shall prepare and file
with the Commission (x) no earlier than (i) seventy five (75) days following the
Funding Date or (ii) the date on which the Holder shall have given written
notice to the Company that it has waived its right to exercise the opition (as
defined in the Securities Purchase Agreement) and (y) no later than one hundred
twenty (120 days after May 15, 2000 (the "Benchmark Date"), a Registration
Statement relating to the offer and sale of all of the Common Stock issuable
upon exercise of the Warrants and shall use its best efforts to cause the
Commission to declare such Registration Statement effective under the Securities
Act as promptly as practicable but not later than one hundred ninety five (195)
days after the Benchmark Date no later than one hundred and fifty (150) days
after the Funding Date (the "150th Day"), provided, however, that the Company
may, upon prior written notice to the Holder, elect to extend the time within
which said Registration Statement shall be filed and declared effective to such
dates that are fifteen (15) days after 60th Day and the 150th Day, respectively.

         9.4 Termination of Restrictions. Notwithstand-ing the foregoing
provisions of Section 9, the restrictions imposed by this Section upon the
transferability of the Warrants, the Warrant Shares and the Restricted Common
Stock and the legend requirements of Section 9.1 shall terminate as to any
particular Warrant or Warrant Shares or shares of Restricted Common Stock (i)
when and so long as such security shall have been effectively registered under
the Securities Act and disposed of pursuant thereto or (ii) when the Company
shall have received an opinion of counsel reasonably satisfactory to it and its
counsel that such shares may be transferred without registration thereof under
the Securities Act. Whenever the restrictions imposed by Section 9 shall
terminate as to this Warrant, as hereinabove provided, the Holder hereof shall
be entitled to receive from the Company upon written request of the Holder, at
the expense of the Company, a new Warrant bearing the following legend in place
of the restrictive legend set forth hereon:

                  "THE RESTRICTIONS ON TRANSFERABILITY OF THE WITHIN WARRANT
                  CONTAINED IN SECTION 9 HEREOF

<PAGE>

                  TERMINATED ON , AND ARE OF NO FURTHER FORCE AND EFFECT."

All Warrants issued upon registration of transfer, division or combination of,
or in substitution for, any Warrant or Warrants entitled to bear such legend
shall have a similar legend endorsed thereon. Whenever the restrictions imposed
by this Section shall terminate as to any share of Restricted Common Stock, as
hereinabove provided, the holder thereof shall be entitled to receive from the
Company, at the Company's expense, a new certificate representing such Common
Stock not bearing the restrictive legend set forth in Section 9.1(b).

         9.5 Listing on Securities Exchange. If the Company shall list any
shares of Common Stock on any securities exchange, it will, at its expense, list
thereon, maintain and, when necessary, increase such listing of, all shares of
Common Stock issued or, to the extent permissible under the applicable
securities exchange rules, issuable upon the exercise of this Warrant so long as
any shares of Common Stock shall be so listed during any such Exercise Period.

10.      SUPPLYING INFORMATION

         The Company shall cooperate with Holder in supplying such information
as may be reasonably necessary for Holder to complete and file any information
reporting forms presently or hereafter required by the Commission as a condition
to the availability of an exemption from the Securities Act for the sale of any
Warrant or Restricted Common Stock.

11.      LOSS OR MUTILATION

         Upon receipt by the Company from Holder of evidence reasonably
satisfactory to it of the ownership of and the loss, theft, destruction or
mutilation of this Warrant and indemnity reasonably satisfactory to it (it being
understood that the written agreement of the Holder shall be sufficient
indemnity), and in case of mutilation upon surrender and cancellation hereof,
the Company will execute and deliver in lieu hereof a new Warrant of like tenor
to Holder; provided, in the case of mutilation, no indemnity shall be required
if this Warrant in identifiable form is surrendered to the Company for
cancellation.

12.      OFFICE OF THE COMPANY

         As long as any of the Warrants remain outstanding, the Company shall
maintain an office or agency (which may be the principal executive offices of
the Company) where the Warrants may be presented for exercise, registration of
transfer, division or combination as provided in this Warrant.

13.      LIMITATION OF LIABILITY

         No provision hereof, in the absence of affirmative action by Holder to
purchase shares of Common Stock, and no enumeration herein of the rights or
privileges of Holder hereof, shall give rise to any liability of Holder for the
purchase price of any Common Stock or as a stockholder of the Company, whether
such liability is asserted by the Company or by creditors of the Company,

<PAGE>

and the holder shall have no rights as a shareholder of the Company arising from
its status as a Holder of the Warrants.

14.      MISCELLANEOUS

         14.1 Nonwaiver and Expenses. No course of deal-ing or any delay or
failure to exercise any right hereunder on the part of Holder shall operate as a
waiver of such right or otherwise prejudice Holder's rights, powers or remedies.
If the Company fails to make, when due, any payments provided for hereunder, or
fails to comply with any other provision of this Warrant, the Company shall pay
to Holder such amounts as shall be sufficient to cover any reasonable costs and
expenses including, but not limited to, reasonable attorneys' fees, including
those of appellate proceedings, incurred by Holder in collecting any amounts due
pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.

         14.2 Notice Generally. Except as may be otherwise provided herein, any
notice or other communication or delivery required or permitted hereunder shall
be in writing and shall be sent by facsimile with a copy delivered personally or
sent by a nationally recognized overnight courier service, and shall be deemed
given when so delivered personally or by overnight courier service, as follows:

         (1) if to the Company, to:

                  SYMPOSIUM CORPORATION
                  410 Park Avenue, Suite 830
                  New York, New York 10022
                  Attention: Robert Altbach
                  Chairman and Chief Executive Officer
                  Telephone: (212) 754-9901
                  Facsimile: (212) 754-9906

                  With a copy to:

                  KRAMER LEVIN NAFTALIS & FRANKEL LLP
                  919 Third Avenue
                  New York, NY 10022
                  Attention: Howard J. Rothman, Esq.
                  Telephone: (212) 715-9242
                  Facsimile: (212) 715-8000

         (2)      if to the Holder, to:

                  THE SHAAR FUND LTD.,
                  c/o SHAAR ADVISORY SERVICES LTD.

<PAGE>

                  62 King George Street, Apartment 4F
                  Jerusalem, Israel
                  Attention: Samuel Levinson

                  with a copy to:

                  HERRICK, FEINSTEIN LLP
                  2 Park Avenue
                  New York, New York 10016
                  Attention: Irwin A. Kishner, Esq.
                  Telephone: (212) 592-1400
                  Facsimile: (212) 889-7577

The Company or the Holder may change the foregoing address by notice given
pursuant to this Section 14.2.

         14.3 Indemnification. The Company agrees to indemnify and hold harmless
Holder from and against any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, claims, costs, attorneys' fees, expenses
and disbursements of any kind which may be imposed upon, incurred by or asserted
against Holder in any manner relating to or arising out of any failure by the
Company to perform or observe in any material respect any of its covenants,
agreements, undertakings or obligations set forth in this Warrant; provided,
however, that the Company will not be liable hereunder to the extent that any
liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
claims, costs, attorneys' fees, expenses or disburse-ments are found in a final
non-appealable judgment by a court to have resulted from Holder's gross
negligence, bad faith or willful misconduct in its capacity as a stockholder or
warrantholder of the Company.

         14.4 Remedies. Holder in addition to being entitled to exercise all
rights granted by law, including recovery of damages, will be entitled to
specific performance of its rights under Section 9 of this Warrant. The Company
agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of Section 9 of this
Warrant and hereby agrees to waive the defense in any action for specific
performance that a remedy at law would be adequate.

         14.5 Successors and Assigns. Subject to the provisions of Sections 3.1
and 9, this Warrant and the rights evidenced hereby shall inure to the benefit
of and be binding upon the successors of the Company and the successors and
assigns of Holder. The provisions of this Warrant are intended to be for the
benefit of all Holders from time to time of this Warrant and, with respect to
Section 9 hereof, holders of Warrant Shares, and shall be enforceable by any
such Holder or holder of Warrant Shares.

         14.6 Amendment. This Warrant and all other Warrants may be modified or
amended or the provisions hereof waived with the written consent of the Company
and the Holder.

         14.7 Severability. Wherever possible, each provision of this Warrant
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision

<PAGE>

of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity,
without invalidating the remainder of such provision or the remaining provisions
of this Warrant.

         14.8 Headings. The headings used in this Warrant are for the
convenience of reference only and shall not, for any purpose, be deemed a part
of this Warrant.

         14.9 Governing Law. This Warrant shall be governed by the laws of the
State of Delaware, without regard to the provisions thereof relating to conflict
of laws.

               IN WITNESS WHEREOF, the Company has caused this Warrant to be
duly executed and its corporate seal to be impressed hereon and attested by its
Secretary or an Assistant Secretary.

Dated:   June 9, 2000

                                  THE COMPANY:
                                  -----------

                                  SYMPOSIUM CORPORATION

                                  By: ________________________________
                                  Ronald Altbach
                                  Chairman and Chief Executive Officer

[SEAL]

<PAGE>

                                    EXHIBIT A

                                SUBSCRIPTION FORM

                 [To be executed only upon exercise of Warrant]

         The undersigned registered owner of this Warrant irrevocably exercises
this warrant for the purchase of Shares of Common Stock of Symposium Corporation
and herewith makes payment therefor, all at the price and on the terms and
conditions specified in this Warrant and requests that certificates for the
shares of Common Stock hereby purchased (and any securities or other property
issuable upon such exercise) be issued in the name of and delivered to
_____________________ whose address is______________________ and, if such shares
of Common Stock shall not include all of the shares of Common Stock issuable as
provided in this Warrant, that a new Warrant of like tenor and date for the
balance of the shares of Common Stock issuable hereunder be delivered to the
undersigned.

                           (Name of Registered owner)

                        (Signature of Registered Owner)

                                (Street Address)

                                     (City)                  (State)(Zip Code)

NOTICE:  The signature on this subscription must correspond with the name as
         written upon the face of the within Warrant in every particular,
         without alteration or enlargement or any change whatsoever.

<PAGE>

                                    EXHIBIT B

                                 ASSIGNMENT FORM

                  FOR VALUE RECEIVED the undersigned registered owner of this
Warrant hereby sells, assigns and transfers unto the Assignee named below all of
the rights of the undersigned under this Warrant, with respect to the number of
shares of Common Stock set forth below:

                                                              No. of Shares of
Name and Address of Assignee                                  Common Stock
----------------------------                                  ------------

and does hereby irrevocably constitute and appoint attorney-in-fact to register
such transfer on the books of maintained for the purpose, with full power of
substitution in the premises.

                Dated:                                Print Name:

                                                      Signature:

                                                      Witness:

NOTICE:  The signature on this assignment must correspond with the name as
         written upon the face of the within Warrant in every particular,
         without alteration or enlargement or any change whatsoever.

REPRESENTATION AND COVENANT OF ASSIGNEE:

         Assignee hereby represents and covenants that neither assignee, its
affiliates, nor any person acting on its or their behalf has entered into or
will enter into, at any time prior to the exercise of the Warrants, any put
option, short position or other similar instrument or position with respect to
the Common Stock, and neither assignee, any of its affiliates, nor any person
acting on its or their behalf has or will use at any time shares of Common Stock
acquired pursuant to this warrant or otherwise to settle any put option, short
position or other similar instrument or position that may have been entered into
prior to the execution of this assignment

                                                     ASSIGNEE:

                                                     By: ____________________
                                                         Name:
                                                         Title

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00010-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00010-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00010-of-00352.parquet"}]]